Funded Tech Companies
F2G
F2G, based in Manchester, received investment capital through Brace Pharma, Morningside Group and Novo Ventures.
Company Overview
Company Name
F2G
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Lankro Way Eccles
Manchester, M30 0LX
UK
Manchester, M30 0LX
UK
Phone
Website
Email Address
Company Background Information
Overview
F2G is a world leading UK biotech company focused on the discovery and development of novel therapies to treat life threatening invasive fungal infections, with experienced management and board. F2G has discovered and developed a completely new class of antifungal agents called the orotomides.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/13/2020
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ian Nicholson
Chief Financial Officer
Ralf Schmid
Chief Medical Officer
Emma Harvey
Chief Medical Officer
John Rex
Chief Operating Officer
Michael Birch
Chief Scientific Officer
Tony Kennedy
Company Investors
- Brace Pharma
- Morningside Group
- Novo Ventures
- Cowen Capital Partners (Timothy Anderson)
- Advent Life Sciences
- Novartis Venture Fund
- Sunstone Capital
- Aisling Capital
- Sectoral Asset Management (Maha Katabi)
Browse more funded tech companies:
Share this article
About Our VC Deals Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs